Addus HomeCareADUS
About: Addus HomeCare Corp is engaged in the provision of in-home personal care services. It operates through the segments such as Personal care segment, which is a key revenue driver, provides non-medical assistance with activities of daily living, primarily to persons who are at risk of hospitalization or institutionalization, such as the elderly, chronically ill and disabled. The Hospice segment provides physical, emotional and spiritual care for people who are terminally ill and their families. Its Home health segment provides services that are primarily medical in nature to those individuals who may require assistance during an illness or after surgery.
Employees: 34,846
Fund manager confidence
Based on 2024 Q2 SEC filings by fund managers ($100M+ AUM)
105% more call options, than puts
Call options by funds: $2.79M | Put options by funds: $1.36M
92% more first-time investments, than exits
New positions opened: 48 | Existing positions closed: 25
23% more capital invested
Capital invested by funds: $1.65B [Q1] → $2.03B (+$376M) [Q2]
9% more funds holding
Funds holding: 261 [Q1] → 284 (+23) [Q2]
8.19% more ownership
Funds ownership: 98.76% [Q1] → 106.95% (+8.19%) [Q2]
9% more repeat investments, than reductions
Existing positions increased: 104 | Existing positions reduced: 95
0% more funds holding in top 10
Funds holding in top 10: 1 [Q1] → 1 (+0) [Q2]
Research analyst outlook
7 Wall Street Analysts provided 1 year price targets over the past 3 months
7 analyst ratings
Oppenheimer Michael Wiederhorn 69% 1-year accuracy 25 / 36 met price target | 15%upside $145 | Outperform Maintained | 23 Sept 2024 |
RBC Capital Ben Hendrix 64% 1-year accuracy 39 / 61 met price target | 12%upside $141 | Outperform Reiterated | 3 Sept 2024 |
RBC Capital Ben Hendrix 64% 1-year accuracy 39 / 61 met price target | 12%upside $141 | Outperform Maintained | 8 Aug 2024 |
TD Cowen Ryan Langston 100% 1-year accuracy 4 / 4 met price target | 8%upside $137 | Buy Maintained | 8 Aug 2024 |
Stephens & Co. Scott Fidel 84% 1-year accuracy 27 / 32 met price target | 13%upside $143 | Overweight Maintained | 7 Aug 2024 |